Lixte Biotechnology Holdings, Inc. announced the appointment of Dr. James Miser as its Chief Medical Officer commencing August 1, 2020. Dr. Miser is a pediatric hematologist/oncologist, internationally recognized as an expert in the study and treatment of childhood cancers. His outstanding career includes positions of major responsibility at: Seattle Children’s Hospital and City of Hope National Medical Center, where he served as President, Chief Executive Officer and Chief Medical Officer. Most recently, Dr. Miser has been dividing his time between serving as a member of the Active Staff in the Department of Pediatrics at City of Hope and being Chair Professor, College of Medical Sciences and Technology, Taipei Medical University, Taipei, Taiwan. Dr. Miser has extensive experience in the clinical development of new anticancer drugs for pediatric malignancies, leading many clinical trials at institutional and national cancer study groups.